NEwsletters
July 2023
Interested in learning about Generative AI for de novo drug design? Iktos hosted a webinar on ‘Where do we start if we don’t have any data? AI for early-stage projects …Read more
April 2023
Iktos announces the closing of a € 15.5m Series A financing to expand its artificial intelligence-based drug discovery technologies and solutions …Read more
January 2023
Peptides are a promising class of therapeutics with unique properties. They share some advantages of proteins, such as their high selectivity but also some of …Read more
October 2022
Our CSO, Dr. Quentin Perron and VP, Head of BD- EU, RoW Dr. Sree Vadlamudi presented a webinar on ‘Makya™ …Read more
August 2022
Take a tour of our new website and explore our AI-driven generative modeling technology platform …Read more
April 2022
We are very pleased to announce our 2nd Annual ‘AI for De Novo Drug Design’ Conference to be held virtually on May 3 and 4, 2022…Read more